中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 11
Nov.  2022
Turn off MathJax
Article Contents

A case of type 3 progressive familial intrahepatic cholestasis

DOI: 10.3969/j.issn.1001-5256.2022.11.025
Research funding:

Chengdu Science and Technology Bureau Technology Innovation R & D Project (2021-YF05-01040-SN)

More Information
  • Corresponding author: LEI Lei, leileixhnk@qq.com(ORCID: 0000-0002-3725-1968)
  • Received Date: 2022-03-13
  • Accepted Date: 2022-05-11
  • Published Date: 2022-11-20
  • loading
  • [1]
    LIPIŃSKI P, JANKOWSKA I. Progressive familial intrahepatic cholestasis type 3[J]. Dev Period Med, 2018, 22(4): 385-389. DOI: 10.34763/devperiodmed.20182204.385389.
    [2]
    AMIRNENI S, HAEP N, GAD MA, et al. Molecular overview of progressive familial intrahepatic cholestasis[J]. World J Gastroenterol, 2020, 26(47): 7470-7484. DOI: 10.3748/wjg.v26.i47.7470.
    [3]
    LI AQ, DONG Y, XU ZQ, et al. Progressive familial intrahepatic cholestasis type 3: A report of two cases in one pedigree[J]. J Clin Hepatol, 2020, 36(7): 1601-1604. DOI: 10.3969/j.issn.1001-5256.2020.07.032.

    李爱芹, 董漪, 徐志强, 等. 进行性家族性肝内胆汁淤积症3型一家系2例报告[J]. 临床肝胆病杂志, 2020, 36(7): 1601-1604. DOI: 10.3969/j.issn.1001-5256.2020.07.032.
    [4]
    STÄTTERMAYER AF, HALILBASIC E, WRBA F, et al. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults[J]. J Hepatol, 2020, 73(3): 651-663. DOI: 10.1016/j.jhep.2020.04.036.
    [5]
    GUNAYDIN M, BOZKURTER CIL AT. Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment[J]. Hepat Med, 2018, 10: 95-104. DOI: 10.2147/HMER.S137209.
    [6]
    DEGIORGIO D, COLOMBO C, SEIA M, et al. Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3)[J]. Eur J Hum Genet, 2007, 15(12): 1230-1238. DOI: 10.1038/sj.ejhg.5201908.
    [7]
    REICHERT MC, LAMMERT F. ABCB4 gene aberrations in human liver disease: An evolving spectrum[J]. Semin Liver Dis, 2018, 38(4): 299-307. DOI: 10.1055/s-0038-1667299.
    [8]
    LAZARIDIS KN, GORES GJ, LINDOR KD. Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'[J]. J Hepatol, 2001, 35(1): 134-146. DOI: 10.1016/s0168-8278(01)00092-7.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)

    Article Metrics

    Article views (563) PDF downloads(37) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return